Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Heald
Andrew Bruce Heald, Wellington NZ
| Patent application number | Description | Published |
|---|---|---|
| 20110211424 | Acoustic Transducer for Swath Beams - A swath beam acoustic transducer ( | 09-01-2011 |
Michael Heald, Cheshire GB
| Patent application number | Description | Published |
|---|---|---|
| 20120095409 | SEAL MEMBER - A seal member is configured to seal a chamber of a drug delivery device which is suitable to contain a drug, wherein the seal member comprises a diaphragm. | 04-19-2012 |
| 20120095414 | DRUG DELIVERY DEVICE - Drug delivery device, comprising a body unit having a first opening and a second opening, a plunger arranged such that its distal end is positioned inside the body unit, wherein the plunger is moveable in the distal direction with respect to the body unit, a needle assembly, with a proximal end and a distal end comprising a needle, wherein the proximal end of the needle assembly and the distal end of the plunger are configured such that they can get into an adhesion connection. | 04-19-2012 |
| 20120095438 | MEDICATION DELIVERY DEVICE WITH FOLDABLE FINGER PAD - A medication delivery device is configured to deliver medication when a button element is moved, the medication delivery device having a folding finger pad. | 04-19-2012 |
| 20120101446 | SYRINGE, AUTO-INJECTOR DEVICE AND SET OF AUTO-INJECTOR DEVICES AND SYRINGES - A syringe comprising a first coding feature for mechanical interaction with a second coding feature of an auto-injector device is provided. The first coding feature is designed such that the syringe is only mountable in an auto-injector device having a second coding feature mating the first coding feature. Furthermore, an auto-injector device having a housing, wherein a syringe can be mounted, and a set of at least two auto-injector devices and syringes are provided. | 04-26-2012 |
| 20120116306 | NEEDLE UNIT - A needle unit for a drug delivery device, wherein the needle unit comprises a needle which is retractable into the drug delivery device from a starting position to an end position and a needle retainer having a stop member. The stop member is configured to prevent a re-exposure of the needle when the needle has been retracted into the drug delivery device. | 05-10-2012 |
| 20120116320 | Drug Delivery Device - Drug delivery device, comprising a body unit having a first opening and a second opening, a plunger arranged such that its distal end is positioned inside the body unit, wherein the plunger is moveable in the distal direction with respect to the body unit, a needle assembly, with a proximal end and a distal end comprising a needle, wherein the proximal end of the needle assembly and the distal end of the plunger are configured such that they can get into a vacuum connection. | 05-10-2012 |
| 20120123351 | Needle Assembly - A needle assembly ( | 05-17-2012 |
| 20120136318 | Drug Delivery Device with Retractable Needle - Drug delivery device, comprising a needle, which a distal end and a proximal end comprises an inner surface forming a channel, an outer surface, a first salient located on the outer surface. | 05-31-2012 |
Michael James Heald, Cheshire GB
| Patent application number | Description | Published |
|---|---|---|
| 20120136334 | Delivery of Two or More Medicaments Through a Single Dose Selection and Dispense Interface - An injection system for co-delivery of two medicaments ( | 05-31-2012 |
Michael James David Heald, Berkshire GB
| Patent application number | Description | Published |
|---|---|---|
| 20120116349 | Medicated Module with Premix Medicament - A medicated module ( | 05-10-2012 |
| 20120130346 | Medicated Module for a Drug Delivery Device - A medicated module ( | 05-24-2012 |
Robert Heald, Harlow GB
| Patent application number | Description | Published |
|---|---|---|
| 20100004269 | 5-ANILINOIMIDAZOPYRIDINES AND METHODS OF USE - The invention relates to imidazopyridines of formula I with anti-cancer and/or anti-inflammatory activity and more specifically to imidazopyridines which inhibit MEK kinase activity. The invention provides compositions and methods useful for inhibiting abnormal cell growth or treating a hyperproliferative disorder, or treating an inflammatory disease in a mammal. The invention also relates to methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions. | 01-07-2010 |
| 20110158990 | 5-ANILINOIMIDAZOPYRIDINES AND METHODS OF USE - The invention relates to a method of inhibiting abnormal cell growth or treating a hyperproliferative disorder in a mammal comprising administering to said mammal a therapeutically effective amount of an imidazopyridine of formula I with anti-hyperproliferative activity. | 06-30-2011 |
Robert Heald, Essex GB
| Patent application number | Description | Published |
|---|---|---|
| 20100280063 | 8-ANILINOIMIDAZOPYRIDINES AND THEIR USE AS ANTI-CANCER AND/OR ANTI-INFLAMMATORY AGENTS - The invention relates to imidazopyridines of formula I with anti-cancer and/or anti-inflammatory activity and more specifically to imidazopyridines which inhibit MEK kinase activity. The invention provides compositions and methods useful for inhibiting abnormal cell growth or treating a hyperproliferative disorder, or treating an inflammatory disease in a mammal. The invention also relates to methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions. | 11-04-2010 |
| 20110142826 | AZAINDOLIZINES AND METHODS OF USE - The invention relates to azaindolizines of formula I-a or I-b with anti-cancer and/or anti-inflammatory activity and more specifically to azaindolizines which inhibit MEK kinase activity. The invention provides compositions and methods useful for inhibiting abnormal cell growth or treating a hyperproliferative disorder, or treating an inflammatory disease in a mammal. The invention also relates to methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions. | 06-16-2011 |
Robert Andrew Heald, Harlow Essex GB
| Patent application number | Description | Published |
|---|---|---|
| 20110124622 | ISOINDOLONES DERIVATIVES AS MEK KINASE INHIBITORS AND METHODS OF USE - The invention relates to isoindolones of formula, (I) with anti-cancer and/or anti-inflammatory activity and more specifically with MEK kinase inhibitory activity. The invention provides compositions and methods useful for inhibiting abnormal cell growth, treating a hyperproliferative disorder, or treating an inflammatory disease in a mammal. The invention also relates to methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions. | 05-26-2011 |
| 20110190257 | BICYCLIC HETEROCYCLES AS MEK KINASE INHIBITORS - The invention relates to bicyclic heterocycles of formulae I and II with anti-cancer and/or anti-inflammatory activity and more specifically with MEK kinase inhibitory activity. The invention provides compositions and methods useful for inhibiting abnormal cell growth, treating a hyperproliferative disorder, or treating an inflammatory disease in a mammal. The invention also relates to methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions. | 08-04-2011 |
Robert Andrew Heald, Essex GB
Steve Heald, Canterbury GB
| Patent application number | Description | Published |
|---|---|---|
| 20110268858 | PREPARATION OF VANILLIN FROM MICROBIAL TRANSFORMATION MEDIA BY EXTRACTION BY MEANS SUPERCRITICAL FLUIDS OR GASES - Crude solid vanillin-containing material is precipitated from a solution obtained by biotransformation, and purified by a process comprising contacting it with a purification fluid selected from (a) a liquefied gas whose pressure exceeds its critical pressure and whose temperature is below its critical temperature; (b) a supercritical fluid; (c) a gas. The fluid is preferably liquid carbon dioxide. The temperature is maintained below 25° . The product may be further purified by treatment with CO | 11-03-2011 |
Victor Heald, York Yorkshire GB
| Patent application number | Description | Published |
|---|---|---|
| 20100136180 | METHOD AND APPARATUS FOR MAKING CENTRE-FILLED SHAPED FOOD PRODUCTS - The present invention relates to an apparatus for making a food product ( | 06-03-2010 |